Serum 25-hydroxyvitamin D3 is associated with homocysteine more than with apolipoprotein B

키워드

참고문헌 (41)

1. Roth GA, "Global burden of cardiovascular diseases and risk factors, 1990–2019 : update from the GBD 2019 study", J Am Coll Cardiol, 76, pp.2982~3021 (2020)
2. Shin JI, "Current state of cardiovascular research in Korea", Circ Res, 125, pp.1141~1145 (2019)
3. Tousoulis D, "Innate and adaptive inflammation as a therapeutic target in vascular disease : the emerging role of statins", J Am Coll Cardiol, 63, pp.2491~2502 (2014)
4. Young KA, "Vitamin D deficiency and coronary artery calcification in subjects with type 1 diabetes", Diabetes Care, 34, pp.454~458 (2011)
5. Lavie CJ, "Vitamin D and cardiovascular disease will it live up to its hype?", J Am Coll Cardiol, 58, pp.1547~1556 (2011)
6. Lee JH, "Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?", J Am Coll Cardiol, 52, pp.1949~1956 (2008)
7. Ganguly P, "Role of homocysteine in the development of cardiovascular disease", Nutr J, 14, pp.6~ (2015)
8. Joo NS, "Cut-offvalue of serum homocysteine in relation to increase of coronary artery calcification", J Investig Med, 69, pp.345~350 (2021)
9. Sniderman AD, "Apolipoprotein B particles and cardiovascular disease : a narrative review", JAMA Cardiol, 4, pp.1287~1295 (2019)
10. Chan DC, "Apolipoproteins as markers and managers of coronary risk", QJM, 99, pp.277~287 (2006)
11. Melguizo-Rodríguez L, "Role of vitamin D in the metabolic syndrome", Nutrients, 13, pp.830~ (2021)
12. 정지윤, "Vitamin D status and its association with cardiometabolic risk factors in Korean adults based on a 2008-2010 Korean National Health and Nutrition Examination Survey", Nutrition Research and Practice, 7(6), pp.495~502 (2013), 한국영양학회
13. Lee SJ, "Associations of serum 25-hydroxyvitamin D with metabolic syndrome and its components in elderly men and women : the Korean Urban Rural Elderly cohort study", BMC Geriatr, 19, pp.102~ (2019)
14. Manson JE, "Vitamin D supplements and prevention of cancer and cardiovascular disease", N Engl J Med, 380, pp.33~44 (2019)
15. Jani R, "Circulating 25-hydroxy-vitamin D and the risk of cardiovascular diseases. Systematic review and meta-analysis of prospective cohort studies", Nutr Metab Cardiovasc Dis, 31, pp.3282~3304 (2021)
16. Han D, "Incremental benefit of coronary artery calcium score above traditional risk factors for all-cause mortality in asymptomatic Korean adults", Circ J, 79, pp.2445~2451 (2015)
17. Rai V, "Role of vitamin D in cardiovascular diseases", Endocrinol Metab Clin North Am, 46, pp.1039~1059 (2017)
18. 김선혜, "The factors associated with Vitamin D deficiency in community dwelling elderly in Korea", Nutrition Research and Practice, 12(5), pp.387~395 (2018), 한국영양학회
19. 박선민, "Vitamin D deficiency is an independent risk factor for cardiovascular disease in Koreans aged ≥ 50 years: results from the Korean National Health and Nutrition Examination Survey", Nutrition Research and Practice, 6(2), pp.162~168 (2012), 한국영양학회[DOI]
20. Cholesterol Treatment Trialists’ (CTT) Collaboration, "Efficacy and safety of more intensive lowering of LDL cholesterol : a meta-analysis of data from 170, 000 participants in 26 randomised trials", Lancet, 376, pp.1670~1681 (2010)
21. Barter PJ, "Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy : report of the thirty-person", ten-country panel, 2006, pp.259, 247~258
22. Sniderman AD, "A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk", Circ Cardiovasc Qual Outcomes, 4, pp.337~345 (2011)
23. Thanassoulis G, "Relations of change in plasma levels of LDL-C, non-HDL-C and ApoB with risk reduction from statin therapy : a meta-analysis of randomized trials", J Am Heart Assoc, 3, pp.e000759~ (2014)
24. Borén J, "The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis : a triumph of simplicity", Curr Opin Lipidol, 27, pp.473~483 (2016)
25. Langlois MR, "Quantifying atherogenic lipoproteins: current and future challenges in the era of personalized medicine and very low concentrations of LDL cholesterol. A consensus statement from EAS and EFLM", Clin Chem, 64, pp.1006~1033 (2018)
26. Karhapää P, "Diverse associations of 25-hydroxyvitamin D and 1, 25-dihydroxy-vitamin D with dyslipidaemias", J Intern Med, 268, pp.604~610 (2010)
27. Sun X, "Associations between the serum 25(OH)D concentration and lipid profiles in Japanese men", J Atheroscler Thromb, 22, pp.355~362 (2015)
28. Li S, "Increase of circulating cholesterol in vitamin D deficiency is linked to reduced vitamin D receptor activity via the Insig-2", SREBP-2 pathway, 2016, pp.60, 798~809
29. Schaffer A, "Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study", Thromb Res, 134, pp.288~293 (2014)
30. Wald DS, "Homocysteine and cardiovascular disease : evidence on causality from a meta-analysis", BMJ, 325, pp.1202~1206 (2002)
31. Faraci FM, "Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction", Stroke, 35, pp.345~347 (2004)
32. Esse R, "The contribution of homocysteine metabolism disruption to endothelial dysfunction : state-of-the-art", Int J Mol Sci, 20, pp.867~ (2019)
33. Li WF, "The association between B vitamins supplementation and adverse cardiovascular events : a meta-analysis", Int J Clin Exp Med, 7, pp.1923~1930 (2014)
34. Martí-Carvajal AJ, "Homocysteine-lowering interventions for preventing cardiovascular events", Cochrane Database Syst Rev, 8, pp.CD006612~ (2017)
35. Al-Bayyari N, "Vitamin D3 prevents cardiovascular diseases by lowering serum total homocysteine concentrations in overweight reproductive women : A randomized, placebo-controlled clinical trial", Nutr Res, 59, pp.65~71 (2018)
36. Mao X, Xing X, Xu R, Gong Q, He Y, Li S, Wang H, Liu C, Ding X, Na R, et al, "Folic acid and vitamins D and B12 correlate with homocysteine in Chinese patients with type-2 diabetes mellitus, hypertension, or cardiovascular disease", Medicine (Baltimore), 95, pp.e2652~ (2016)
37. Verdoia M, "Association between vitamin D deficiency and serum Homocysteine levels and its relationship with coronary artery disease", J Thromb Thrombolysis, 52, pp.523~531 (2021)
38. Amer M, "The relationship between 25-hydroxyvitamin D and homocysteine in asymptomatic adults", J Clin Endocrinol Metab, 99, pp.633~638 (2014)
39. Glueck CJ, "Associations between serum 25-hydroxyvitamin D and lipids, lipoprotein cholesterols, and homocysteine", N Am J Med Sci, 8, pp.284~290 (2016)
40. Kriebitzsch C, "1, 25-dihydroxyvitamin D3 influences cellular homocysteine levels in murine preosteoblastic MC3T3-E1 cells by direct regulation of cystathionine β-synthase", J Bone Miner Res, 26, pp.2991~3000 (2011)
41. Jung SJ, "Recent trends in serum vitamin D levels among Korean population : Korea National Health and Nutrition Examination Survey 2008~2014", Korean J Clin Geriatr, 19, pp.55~62 (2018)

관련 논문AI추천